NCT06252441View on ClinicalTrials.gov

Comparative Clinical Study to Evaluate the Possible Efficacy and Safety of Oral N-Acetyl Cysteine Versus Rectal Diclofenac in the Prevention of Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

February 29, 2024

Primary Completion Date

April 30, 2025

Study Completion Date

May 31, 2025

Conditions
Post ERCP Pancreatitis
Interventions
DRUG

Rectal Diclofenac

100 mg Rectal Diclofenac Before ERCP

DRUG

Oral N-acetyl cysteine

1200 mg N-acetyl cysteine in 150 cc water orally before ERCP.

Trial Locations (1)

Unknown

RECRUITING

Obstructive Jaundice Clinic in the National Liver Institute, Menoufia University , Shebin Elkoom, Menofia

All Listed Sponsors
lead

Tanta University

OTHER